VaxInnate - Home

06/29/2009

FierceBiotech Names VaxInnate as One of the “Fierce 15" Biotech Companies of 2009

Vaxinnate is “Fierce,” on Leading Edge of Biotech

05/18/2009

VaxInnate Takes Aim at Swine Flu

What is Vaxinnate doing to address the Swine Flu (H1N1 influenza A) outbreak?

All news

VaxInnate is developing novel, proprietary vaccines for pandemic and seasonal influenza.
Using our proven technology platform, VaxInnate has the potential to produce potent vaccines for a range of infectious diseases and help meet urgent public health needs.

	Vaccine Currently marketed influenza vaccines are based on a development, production and vaccination strategy that ... More



	Toll-Like Receptor (TLR) VaxInnate's TLR technology is based on the ability of "toll-like receptors" (TLRs) to recognize certain molecular patterns... More



	Background Biology The immune system takes two different, yet interdependent approaches to defeating a foreign pathogen... More



	All technologies

	VaxInnate Employees